Next Generation Cancer Diagnostic Devices Market - Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Next Generation Cancer Diagnostic Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next Generation Cancer Diagnostic Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Cancer Diagnostic Devices Overall Market Size
2.1 Global Next Generation Cancer Diagnostic Devices Market Size: 2021 VS 2027
2.2 Global Next Generation Cancer Diagnostic Devices Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Next Generation Cancer Diagnostic Devices Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Next Generation Cancer Diagnostic Devices Players in Global Market
3.2 Top Global Next Generation Cancer Diagnostic Devices Companies Ranked by Revenue
3.3 Global Next Generation Cancer Diagnostic Devices Revenue by Companies
3.4 Global Next Generation Cancer Diagnostic Devices Sales by Companies
3.5 Global Next Generation Cancer Diagnostic Devices Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Next Generation Cancer Diagnostic Devices Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Next Generation Cancer Diagnostic Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Next Generation Cancer Diagnostic Devices Players in Global Market
3.8.1 List of Global Tier 1 Next Generation Cancer Diagnostic Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Next Generation Cancer Diagnostic Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Next Generation Cancer Diagnostic Devices Market Size Markets, 2021 & 2027
4.1.2 Next Generation Sequencing
4.1.3 qPCR & Multiplexing
4.1.4 Lab-on- a- chip (LOAC)
4.1.5 Protein Microarrays
4.1.6 DNA Microarrays
4.1.7 Reverse Transcriptase-PCR (RT-PCR)
4.2 By Type - Global Next Generation Cancer Diagnostic Devices Revenue & Forecasts
4.2.1 By Type - Global Next Generation Cancer Diagnostic Devices Revenue, 2016-2021
4.2.2 By Type - Global Next Generation Cancer Diagnostic Devices Revenue, 2022-2027
4.2.3 By Type - Global Next Generation Cancer Diagnostic Devices Revenue Market Share, 2016-2027
4.3 By Type - Global Next Generation Cancer Diagnostic Devices Sales & Forecasts
4.3.1 By Type - Global Next Generation Cancer Diagnostic Devices Sales, 2016-2021
4.3.2 By Type - Global Next Generation Cancer Diagnostic Devices Sales, 2022-2027
4.3.3 By Type - Global Next Generation Cancer Diagnostic Devices Sales Market Share, 2016-2027
4.4 By Type - Global Next Generation Cancer Diagnostic Devices Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next Generation Cancer Diagnostic Devices Market Size, 2021 & 2027
5.1.2 Biomarker Development
5.1.3 CTC Analysis
5.1.4 Proteomic Analysis
5.1.5 Epigenetic Analysis
5.1.6 Genetic Analysis
5.2 By Application - Global Next Generation Cancer Diagnostic Devices Revenue & Forecasts
5.2.1 By Application - Global Next Generation Cancer Diagnostic Devices Revenue, 2016-2021
5.2.2 By Application - Global Next Generation Cancer Diagnostic Devices Revenue, 2022-2027
5.2.3 By Application - Global Next Generation Cancer Diagnostic Devices Revenue Market Share, 2016-2027
5.3 By Application - Global Next Generation Cancer Diagnostic Devices Sales & Forecasts
5.3.1 By Application - Global Next Generation Cancer Diagnostic Devices Sales, 2016-2021
5.3.2 By Application - Global Next Generation Cancer Diagnostic Devices Sales, 2022-2027
5.3.3 By Application - Global Next Generation Cancer Diagnostic Devices Sales Market Share, 2016-2027
5.4 By Application - Global Next Generation Cancer Diagnostic Devices Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Next Generation Cancer Diagnostic Devices Market Size, 2021 & 2027
6.2 By Region - Global Next Generation Cancer Diagnostic Devices Revenue & Forecasts
6.2.1 By Region - Global Next Generation Cancer Diagnostic Devices Revenue, 2016-2021
6.2.2 By Region - Global Next Generation Cancer Diagnostic Devices Revenue, 2022-2027
6.2.3 By Region - Global Next Generation Cancer Diagnostic Devices Revenue Market Share, 2016-2027
6.3 By Region - Global Next Generation Cancer Diagnostic Devices Sales & Forecasts
6.3.1 By Region - Global Next Generation Cancer Diagnostic Devices Sales, 2016-2021
6.3.2 By Region - Global Next Generation Cancer Diagnostic Devices Sales, 2022-2027
6.3.3 By Region - Global Next Generation Cancer Diagnostic Devices Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Next Generation Cancer Diagnostic Devices Revenue, 2016-2027
6.4.2 By Country - North America Next Generation Cancer Diagnostic Devices Sales, 2016-2027
6.4.3 US Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.4.4 Canada Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.4.5 Mexico Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Next Generation Cancer Diagnostic Devices Revenue, 2016-2027
6.5.2 By Country - Europe Next Generation Cancer Diagnostic Devices Sales, 2016-2027
6.5.3 Germany Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.5.4 France Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.5.5 U.K. Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.5.6 Italy Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.5.7 Russia Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.5.8 Nordic Countries Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.5.9 Benelux Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Next Generation Cancer Diagnostic Devices Revenue, 2016-2027
6.6.2 By Region - Asia Next Generation Cancer Diagnostic Devices Sales, 2016-2027
6.6.3 China Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.6.4 Japan Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.6.5 South Korea Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.6.6 Southeast Asia Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.6.7 India Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Next Generation Cancer Diagnostic Devices Revenue, 2016-2027
6.7.2 By Country - South America Next Generation Cancer Diagnostic Devices Sales, 2016-2027
6.7.3 Brazil Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.7.4 Argentina Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Next Generation Cancer Diagnostic Devices Sales, 2016-2027
6.8.3 Turkey Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.8.4 Israel Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.8.5 Saudi Arabia Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
6.8.6 UAE Next Generation Cancer Diagnostic Devices Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Roche Holding Ltd.?Switzerland)
7.1.1 Roche Holding Ltd.?Switzerland) Corporate Summary
7.1.2 Roche Holding Ltd.?Switzerland) Business Overview
7.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.1.4 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.1.5 Roche Holding Ltd.?Switzerland) Key News
7.2 Abbott Laboratories(US)
7.2.1 Abbott Laboratories(US) Corporate Summary
7.2.2 Abbott Laboratories(US) Business Overview
7.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.2.5 Abbott Laboratories(US) Key News
7.3 Siemens Healthcare(Germany)
7.3.1 Siemens Healthcare(Germany) Corporate Summary
7.3.2 Siemens Healthcare(Germany) Business Overview
7.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.3.5 Siemens Healthcare(Germany) Key News
7.4 Agilent Technologies Inc(Germany)
7.4.1 Agilent Technologies Inc(Germany) Corporate Summary
7.4.2 Agilent Technologies Inc(Germany) Business Overview
7.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.4.5 Agilent Technologies Inc(Germany) Key News
7.5 Illumina Inc.(US)
7.5.1 Illumina Inc.(US) Corporate Summary
7.5.2 Illumina Inc.(US) Business Overview
7.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.5.5 Illumina Inc.(US) Key News
7.6 Becton Dickinson and Co.(US)
7.6.1 Becton Dickinson and Co.(US) Corporate Summary
7.6.2 Becton Dickinson and Co.(US) Business Overview
7.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.6.5 Becton Dickinson and Co.(US) Key News
7.7 QIAGEN N.V.(Germany)
7.7.1 QIAGEN N.V.(Germany) Corporate Summary
7.7.2 QIAGEN N.V.(Germany) Business Overview
7.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.4.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.7.5 QIAGEN N.V.(Germany) Key News
7.8 Affymetrix Inc.(US)
7.8.1 Affymetrix Inc.(US) Corporate Summary
7.8.2 Affymetrix Inc.(US) Business Overview
7.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.8.5 Affymetrix Inc.(US) Key News
7.9 Johnson & Johnson(US)
7.9.1 Johnson & Johnson(US) Corporate Summary
7.9.2 Johnson & Johnson(US) Business Overview
7.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.9.5 Johnson & Johnson(US) Key News
7.10 Thermo Fisher Scientific Inc.(US)
7.10.1 Thermo Fisher Scientific Inc.(US) Corporate Summary
7.10.2 Thermo Fisher Scientific Inc.(US) Business Overview
7.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.10.5 Thermo Fisher Scientific Inc.(US) Key News
7.11 GE Healthcare(England)
7.11.1 GE Healthcare(England) Corporate Summary
7.11.2 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Business Overview
7.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.11.5 GE Healthcare(England) Key News
7.12 Life Technologies Corp.(US)
7.12.1 Life Technologies Corp.(US) Corporate Summary
7.12.2 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Business Overview
7.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.12.4 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.12.5 Life Technologies Corp.(US) Key News
7.13 Luminex Corp.(US)
7.13.1 Luminex Corp.(US) Corporate Summary
7.13.2 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Business Overview
7.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.13.4 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.13.5 Luminex Corp.(US) Key News
7.14 Cepheid Inc.(US)
7.14.1 Cepheid Inc.(US) Corporate Summary
7.14.2 Cepheid Inc.(US) Business Overview
7.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.14.4 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.14.5 Cepheid Inc.(US) Key News
7.15 Allegro Diagnostics Corp.(Brazil)
7.15.1 Allegro Diagnostics Corp.(Brazil) Corporate Summary
7.15.2 Allegro Diagnostics Corp.(Brazil) Business Overview
7.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Major Product Offerings
7.15.4 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales and Revenue in Global (2016-2021)
7.15.5 Allegro Diagnostics Corp.(Brazil) Key News
8 Global Next Generation Cancer Diagnostic Devices Production Capacity, Analysis
8.1 Global Next Generation Cancer Diagnostic Devices Production Capacity, 2016-2027
8.2 Next Generation Cancer Diagnostic Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Next Generation Cancer Diagnostic Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Next Generation Cancer Diagnostic Devices Supply Chain Analysis
10.1 Next Generation Cancer Diagnostic Devices Industry Value Chain
10.2 Next Generation Cancer Diagnostic Devices Upstream Market
10.3 Next Generation Cancer Diagnostic Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Next Generation Cancer Diagnostic Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Next Generation Cancer Diagnostic Devices in Global Market
Table 2. Top Next Generation Cancer Diagnostic Devices Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Next Generation Cancer Diagnostic Devices Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Next Generation Cancer Diagnostic Devices Revenue Share by Companies, 2016-2021
Table 5. Global Next Generation Cancer Diagnostic Devices Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Next Generation Cancer Diagnostic Devices Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Next Generation Cancer Diagnostic Devices Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table 9. List of Global Tier 1 Next Generation Cancer Diagnostic Devices Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Next Generation Cancer Diagnostic Devices Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Roche Holding Ltd.?Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)